Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage

Aaron Kesselheim and colleagues examine orphan-designated drugs approved between 2009 and 2015 in the United States.

Detalles Bibliográficos
Autores principales: Kesselheim, Aaron S., Treasure, Carolyn L., Joffe, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Policy Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207392/
https://www.ncbi.nlm.nih.gov/pubmed/28045970
http://dx.doi.org/10.1371/journal.pmed.1002190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207392/
https://www.ncbi.nlm.nih.gov/pubmed/28045970
http://dx.doi.org/10.1371/journal.pmed.1002190

Ejemplares similares